Methods of treating fungal infections
AssigneeNortheastern University
InventorsKim Lewis, Michael David Lafleur
Life of this patent
Estimating the term…
Abstract
Methods of identifying compounds that potentiate the activity of antifungal agents, potentiators identified by these methods, and methods of using potentiators to treat fungal infections are disclosed.
Claims42
A method of inhibiting the growth of, or killing, a fungus, the method comprising contacting the fungus with an effective amount of:
- (a) an antifungal agent;
- and
- (b) one or more potentiator compounds of Formula I:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
- wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2, thereby inhibiting the growth of, or killing, the fungus.
A method of inhibiting the growth of, or killing, a fungus, the method comprising contacting the fungus with an effective amount of:
- (a) an antifungal agent;
- and
- (b) one or more potentiator compounds of Formula Ia:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
- wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
- thereby inhibiting the growth of, or killing, the fungus.
A method of inhibiting the growth of, or killing, a fungus, the method comprising contacting the fungus with:
- (a) an antifungal agent;
- and
- (b) one or more potentiator compounds of Formula Ib:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
- wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2.
- thereby inhibiting the growth of, or killing, the fungus.
A method of treating a fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
- (a) an antifungal agent;
- in combination with
- (b) an effective amount of one or more potentiator compounds of Formula I:
- or pharmaceutically acceptable salts, hydrates, and solvates hereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl, wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
- thereby treating the fungal infection.
A method of treating a fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of
- (a) an antifungal agent;
- in combination with
- (b) an effective amount of one or more potentiator compounds of Formula Ia:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
- wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
- thereby treating the fungal infection.
A method of treating a fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
- (a) an antifungal agent;
- in combination with
- (b) an effective amount of one or more potentiator compounds of Formula Ib:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
- wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
- thereby treating the fungal infection.
A method of treating or preventing relapsing vaginitis in a subject in need thereof, the method comprising administering to the subject an effective amount of:
- (a) miconazole, in combination with,
- (b) an effective amount of potentiator Compound 1:
- thereby treating the relapsing vaginitis in the subject.
A method of treating or preventing oral candidiasis in a subject in need thereof, the method comprising administering to the subject an effective amount of
- (a) miconazole;
- in combination with,
- (b) an effective amount of potentiator Compound 1:
- thereby treating the oral candidiasis in the subject.
A method of treating a fungal infection of a medical device, the method comprising administering to the device an effective amount of:
- (a) miconazole, in combination with,
- (b) an effective amount of potentiator Compound 1:
- thereby treating the fungal infection.
A method of inhibiting the growth of, or killing, a fungus, the method comprising contacting the fungus with:
- thereby inhibiting the growth of, or killing, the fungus.
A method of treating a fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
- thereby treating the fungal infection.
A method of treating or preventing relapsing vaginitis in a subject in need thereof, the method comprising administering to the subject an effective amount of potentiator Compound 1:
- thereby treating the relapsing vaginitis in the subject.
A method of treating or preventing oral candidiasis in a subject in need thereof, the method comprising administering to the subject an effective amount of potentiator Compound 1:
- thereby treating the oral candidiasis in the subject.
A method of treating a fungal infection of a medical device, the method comprising administering to the device an effective amount of potentiator Compound 1:
- thereby treating the fungal infection of the device.
A method of inhibiting the growth of, or killing, a C. albicans fungus, the method comprising contacting the fungus with an effective amount of:
- (a) an antifungal agent;
- and
- (b) one or more potentiator compounds of Formula I:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
- wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
- thereby inhibiting the growth of, or killing, the fungus.
A method of inhibiting the growth of, or killing, a C. albicans fungus, the method comprising contacting the fungus with an effective amount of:
- (a) an antifungal agent;
- and
- (b) one or more potentiator compounds of Formula Ia:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl, wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen. OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
- thereby inhibiting the growth of, or killing, the fungus.
A method of inhibiting the growth of or killing, a C. albicans fungus, the method comprising contacting the fungus with:
- (a) an antifungal agent;
- and
- (b) one or more potentiator compounds of Formula Ib:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
- wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or
- thereby inhibiting the growth of, or killing, the fungus.
A method of treating a C. albicans fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
- (a) an antifungal agent;
- in combination with
- (b) an effective amount of one or more potentiator compounds of Formula I:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl, wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
- thereby treating the fungal infection.
A method of treating a C. albicans fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
- (a) an antifungal agent;
- in combination with
- (b) an effective amount of one or more potentiator compounds of Formula Ia:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
- wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen, OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
- thereby treating the fungal infection.
A method of treating a C. albicans fungal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of:
- (a) an antifungal agent;
- in combination with
- (b) an effective amount of one or more potentiator compounds of Formula Ib:
- or pharmaceutically acceptable salts, hydrates, and solvates thereof,
- wherein each R1 is independently —OH, —OC(O)H, —OC(O)alkyl, —NH2, —NH-alkyl, —N(alkyl)2, —NH-aminoacid, —NHC(O)alkyl, —NHC(O)aryl, —NH(S(O)2)alkyl,
- wherein the alkyl is optionally substituted, —NH(S(O)2)aryl,
- wherein the aryl is optionally substituted, or a five-membered heteroaryl, optionally substituted with alkyl, halogen. OH, or NH2, or 5- or 6-membered heterocycle, optionally substituted with alkyl, halogen, OH, NH2, or a carbonyl, or alkyl, optionally substituted with alkyl, halogen, OH, or NH2,
- thereby treating the fungal infection.
Dependencies are inferred from the claim text.